Evidence map›Paper›PMID 35881071›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2022

Susceptibility of renal fibrosis in diabetes: Role of hypoxia inducible factor-1.

Shuqin Mei, Lin Li, Xiangjun Zhou, Cheng Xue, Man J Livingston, Qingqing Wei, Bing Dai, Zhiguo Mao, Changlin Mei, Zheng Dong

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Shuqin MeiDepartment of Nephrology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Lin LiDepartment of Nephrology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Xiangjun ZhouDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, China.
Cheng XueDepartment of Nephrology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Man J LivingstonDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University and Charlie Norwood VA Medical Center, Augusta, Georgia, USA.
Qingqing WeiDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University and Charlie Norwood VA Medical Center, Augusta, Georgia, USA.
Bing DaiDepartment of Nephrology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Zhiguo MaoDepartment of Nephrology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Changlin MeiDepartment of Nephrology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Zheng DongDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University and Charlie Norwood VA Medical Center, Augusta, Georgia, USA.
Shanghai Changzheng Hospital · CNAugusta University · USCharlie Norwood VA Medical Center · USWuhan University · CN

Funding

DNA methylation in kidney repair after ischemic AKIR01DK058831 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI DONG, ZHENG · 2001 to 2025
$7.5M
Kidney Injury by Cisplatin and Renoprotective Strategies.R01DK087843 · NIDDK · AUGUSTA UNIVERSITY · PI DONG, ZHENG · 2010 to 2025
$5.8M
Molecular Regulation of Ischemic Renal FailureI01BX000319 · VA · CHARLIE NORWOOD VA MEDICAL CENTER · PI Zheng Dong · 2009 to 2026
–
BLR&D Research Career Scientist Award ApplicationIK6BX005236 · VA · CHARLIE NORWOOD VA MEDICAL CENTER · PI DONG, ZHENG · 2020 to 2025
–
BLRD VA I01 BX000319BLRD VA IK6 BX005236NIDDK NIH HHS R01 DK058831NIDDK NIH HHS R01 DK087843
6 · The paper itself

Abstract

Diabetes may prevent kidney repair and sensitize the kidney to fibrosis or scar formation. To test this possibility, we examined renal fibrosis induced by unilateral ureteral obstruction (UUO) in diabetic mouse models. Indeed, UUO induced significantly more renal fibrosis in both Akita and STZ-induced diabetic mice than in nondiabetic mice. The diabetic mice also had more apoptosis and interstitial macrophage infiltration during UUO. In vitro, hypoxia induced higher expression of the fibrosis marker protein fibronectin in high glucose-conditioned renal tubular cells than in normal glucose cells. Mechanistically, hypoxia induced significantly more hypoxia-inducible factor-1 α (HIF-1 α) in high glucose cells than in normal glucose cells. Inhibition of HIF-1 attenuated the expression of fibronectin induced by hypoxia in high-glucose cells. Consistently, UUO induced significantly higher HIF-1α expression along with fibrosis in diabetic mice kidneys than in nondiabetic kidneys. The increased expression of fibrosis induced by UUO in diabetic mice was diminished in proximal tubule-HIF-1α-knockout mice. Together, these results indicate that diabetes sensitizes kidney tissues and cells to fibrogenesis probably by enhancing HIF-1 activation.

Indexed as

Diabetes Mellitus, ExperimentalKidney DiseasesUreteral ObstructionAnimalsFibronectinsFibrosisGlucoseHypoxiaHypoxia-Inducible Factor 1KidneyMiceFibronectinsGlucoseHypoxia-Inducible Factor 1diabetic kidney diseasefibrosisHIF-1high glucose

Identifiers

PMID35881071
PMCPMC9386694
OpenAlexW4288036758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.